PALISADE CAPITAL MANAGEMENT, LP - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 170 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q1 2017. The put-call ratio across all filers is 1.82 and the average weighting 0.1%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q1 2018$79,000
-52.1%
43,674
-40.8%
0.00%
-50.0%
Q4 2017$165,000
-29.5%
73,774
-8.6%
0.01%
-25.0%
Q3 2017$234,000
-26.2%
80,674
+13.3%
0.01%
-33.3%
Q2 2017$317,000
-60.1%
71,174
-58.3%
0.01%
-60.0%
Q1 2017$795,000
-68.5%
170,505
-58.8%
0.03%
-68.4%
Q4 2016$2,521,000
+3261.3%
413,882
+1432.9%
0.10%
+4650.0%
Q1 2016$75,000
-76.7%
27,000
-55.6%
0.00%
-77.8%
Q3 2015$322,000
+122.1%
60,750
+247.1%
0.01%
+125.0%
Q2 2015$145,00017,5000.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q1 2017
NameSharesValueWeighting ↓
Nantahala Capital Management 11,578,568$20,147,0000.82%
Virtus ETF Advisers LLC 441,461$768,0000.68%
Hikari Power Ltd 2,300,000$4,002,0000.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,403,149$2,441,0000.17%
KNOTT DAVID M 225,400$392,0000.15%
Clear Harbor Asset Management, LLC 277,110$482,0000.09%
Malaga Cove Capital, LLC 97,264$169,0000.09%
Lehman Financial Resources, Inc. 80,800$140,0000.07%
Cheyne Capital Management (UK) LLP 50,000$87,0000.06%
Ballew Advisors, Inc 26,200$46,0000.05%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders